Current Portfolio

Companies

T45

T45 Labs, based in Santa Clara, California, is a medical technology incubator focused on developing minimally invasive technologies that target large addressable markets in the cardiovascular sector. To minimize clinical and commercial risks, T45 Labs pursues a fast-follower strategy to provide higher returns over a shorter period. T45 Fund I is a direct investment vehicle into the portfolio companies of T45 Labs to support the companies’ Series A and Series B financing rounds.

T45 Labs and T45 Fund I leverage a team of accomplished executives and seasoned engineers with numerous years of experience in medical technology investments and development.

Milasard Limited has committed to an investment in T45 Fund I and looks forward to the opportunity to support its impressive portfolio of companies through co-investment in the future.

VahatiCor – developer of a coronary flow reducer for the treatment for angina, due to obstructive and non-obstructive coronary artery disease and heart failure.

NuevoSono – developer of an advanced ultrasound imaging tool for use in minimally invasive surgery.

Advanced NanoTherapies – drug coated balloon technology, licensed from the Clevland Clinic, for the treatment of coronary and peripheral artery disease.

ReCava Medical – device for heart failure management, modulating blood flow to the heart and kidneys.